Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
|
Buy Now
Congestive Heart Failure - Proceedings of the Symposium on New Drugs and Devices October 30-31, 1986, Philadelphia, Pennsylvania (Paperback, Softcover reprint of the original 1st ed. 1987)
Loot Price: R6,151
Discovery Miles 61 510
|
|
Congestive Heart Failure - Proceedings of the Symposium on New Drugs and Devices October 30-31, 1986, Philadelphia, Pennsylvania (Paperback, Softcover reprint of the original 1st ed. 1987)
Series: Developments in Cardiovascular Medicine, 75
Expected to ship within 10 - 15 working days
|
About 2. 5 million individuals have congestive heart fai lure in
the United States with over 400,000 new cases expected annually.
Congestive heart failure also is one of the commonest causes for
hospital admissions accounting for over 5 million hospital days per
year. Despite the early recognition of this condition and active
medical research into both mechanisms and therapy, prognosis
continues to remain dismal wi th less than a 50% expected five year
survival. In the last decade we have seen many new medical and
therapeutic options for patients with congestive heart failure
which extend beyond the use of bed rest, sodium restriction,
digitalis and diuretics. These include vasodilators of a variety of
types including the angiotensin conventional enzyme (ACE)
inhibitors. Also, many new inotropes are under active investigation
both in oral and intravenous forms. In March of 1984 a survey of
over 5000 physicians was performed under the auspices of the
American Heart Association (reported in: JAOC 8:966, 1986). That
survey showed that there was no universally accepted defini tion
for congestive heart fai lure and that a wide spectrum of
diagnostic cri teria for this common condi tion existed even among
academic cardiologists. There was no clear standard as to even the
mos t bas ic treatment of conges t i ve heart fai lure. For
example, exercise restriction was recommended by 19% of physicians,
31% recommended no change in activity, and 50% either light
exercise or an exercise conditioning program.
General
Imprint: |
Springer-Verlag New York
|
Country of origin: |
United States |
Series: |
Developments in Cardiovascular Medicine, 75 |
Release date: |
September 2011 |
First published: |
1987 |
Authors: |
J. Morganroth
• E.Neil Moore
|
Dimensions: |
235 x 155 x 17mm (L x W x T) |
Format: |
Paperback
|
Pages: |
290 |
Edition: |
Softcover reprint of the original 1st ed. 1987 |
ISBN-13: |
978-1-4612-9232-6 |
Categories: |
Books >
Medicine >
Clinical & internal medicine >
Cardiovascular medicine
|
LSN: |
1-4612-9232-8 |
Barcode: |
9781461292326 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.